Duncan Jason — SEC insider filings

SEC reporting owner CIK 1741553. 25 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2020-09-10 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ALBIREO PHARMA, INC. (ALBO)Chief Legal Officer and GC18—29 legs · 27,984 sh · $1,014,77723
Neumora Therapeutics, Inc. (NMRA)See Remarks5——10
enGene Therapeutics Inc. (ENGN)Chief Legal & Admin Officer2——1

Insider filings — Duncan Jason

FiledFormIssuerReported transactionsSource
2026-11-133enGene Therapeutics Inc. (ENGN)Holdings only — no transactions reportedEDGAR
2026-11-134enGene Therapeutics Inc. (ENGN)Grant/award (A): 500,000 (derivative) @ $0EDGAR
2026-08-214Neumora Therapeutics, Inc. (NMRA)Grant/award (A): 375,000 (derivative) @ $0EDGAR
2026-01-094Neumora Therapeutics, Inc. (NMRA)Grant/award (A): 750,000 (derivative) @ $0EDGAR
2025-05-304Neumora Therapeutics, Inc. (NMRA)Disposition to issuer (D): 400,000 (derivative) · Disposition to issuer (D): 500,000 (derivative) · Grant/award (A): 400,000 (derivative) · Grant/award (A): 500,000 (derivative)EDGAR
2025-02-184Neumora Therapeutics, Inc. (NMRA)Grant/award (A): 500,000 (derivative) @ $0 · Disposition to issuer (D): 400,000 (derivative) · Grant/award (A): 400,000 (derivative)EDGAR
2023-12-124Neumora Therapeutics, Inc. (NMRA)Grant/award (A): 400,000 (derivative) @ $0EDGAR
2023-03-024ALBIREO PHARMA, INC. (ALBO)Code (U): 3,296 · Disposition to issuer (D): 15,900 (derivative) · Disposition to issuer (D): 10,063 (derivative) · Disposition to issuer (D): 24,337 (derivative) · Disposition to issuer (D): 23,700 (derivative) · Disposition to issuer (D): 37,500 (derivative) · +1 moreEDGAR
2023-01-274/AALBIREO PHARMA, INC. (ALBO)Grant/award (A): 55,000 @ $0EDGAR
2023-01-254ALBIREO PHARMA, INC. (ALBO)Grant/award (A): 55,000 @ $0EDGAR
2023-01-234ALBIREO PHARMA, INC. (ALBO)Sale (S): 228 @ $43.80EDGAR
2023-01-204ALBIREO PHARMA, INC. (ALBO)Sale (S): 938 @ $43.90EDGAR
2022-10-254ALBIREO PHARMA, INC. (ALBO)Sale (S): 104 @ $19.58 · Sale (S): 96 @ $19.54 · Sale (S): 456 @ $19.40EDGAR
2022-07-254ALBIREO PHARMA, INC. (ALBO)Sale (S): 106 @ $24.68 · Sale (S): 238 @ $24.45 · Sale (S): 93 @ $24.39 · Sale (S): 220 @ $23.66EDGAR
2022-04-254ALBIREO PHARMA, INC. (ALBO)Sale (S): 240 @ $33.07 · Sale (S): 103 @ $32.93 · Sale (S): 221 @ $33.44 · Sale (S): 91 @ $33.40EDGAR
2022-01-254ALBIREO PHARMA, INC. (ALBO)Sale (S): 416 @ $24.88 · Sale (S): 96 @ $25.09 · Sale (S): 1,176 @ $24.94EDGAR
2022-01-204ALBIREO PHARMA, INC. (ALBO)Grant/award (A): 10,800 @ $0 · Grant/award (A): 15,900 (derivative) @ $0EDGAR
2021-10-254ALBIREO PHARMA, INC. (ALBO)Sale (S): 95 @ $28.85 · Sale (S): 217 @ $29.21EDGAR
2021-07-264ALBIREO PHARMA, INC. (ALBO)Sale (S): 90 @ $34.13 · Sale (S): 223 @ $31.43EDGAR
2021-06-284ALBIREO PHARMA, INC. (ALBO)Option exercise (M): 9,137 @ $24.04 · Option exercise (M): 863 @ $24.67 · Sale (S): 10,000 @ $36.38 · Option exercise (M): 6,300 @ $24.67 · Sale (S): 6,300 @ $36.22 · Option exercise (M): 9,137 (derivative) @ $0 · +2 moreEDGAR
2021-04-264ALBIREO PHARMA, INC. (ALBO)Sale (S): 90 @ $31.75 · Sale (S): 222 @ $32.32EDGAR
2021-04-024ALBIREO PHARMA, INC. (ALBO)Sale (S): 1,426 @ $35.04 · Option exercise (M): 300 @ $24.04 · Sale (S): 300 @ $36.16 · Option exercise (M): 300 (derivative) @ $0EDGAR
2021-01-254ALBIREO PHARMA, INC. (ALBO)Grant/award (A): 5,500 @ $0 · Sale (S): 110 @ $34.62 · Grant/award (A): 23,700 (derivative) @ $0EDGAR
2020-10-234ALBIREO PHARMA, INC. (ALBO)Sale (S): 89 @ $34.71EDGAR
2020-09-104ALBIREO PHARMA, INC. (ALBO)Option exercise (M): 3,500 @ $24.04 · Sale (S): 4,000 @ $45.55 · Option exercise (M): 3,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1741553 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs